A medical procedure that uses fluorescent dye in the bloodstream by using an injectable is called fluorescein angiography. The blood vessels at the back of the eyes are highlighted by these dyes so that they can be photographed. By the application of tests like this, various eye disorders can be analyzed and managed. The doctors usually run these tests for monitoring the vessel condition of the eyes, to diagnosis the disorder if any, and make ideal treatments procedure for the same.
After the procedure, the patient might experience some nausea or vomiting. Sometimes the patient also experiences increased salivation, sneezing, dry mouth, and increased heart rate. There have been evidences of some allergic infections to the patients after the procedure which mainly includes:
COVID-19 scenario analysis:
To take care of the infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With a rise in the number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil populations for precautionary measures. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.
Owing to such factors, COVID 19 is expected to have a significant impact on the Fluorescein angiography market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:
The frequencies of reported eye diseases have been increasing in the past years, and it is leading to a demand for the diagnosis at early stages, and the government is coming up with various initiatives and regulations for supporting the growth of the market and proving to be the major factors leading the growth of the fluorescein angiography market. There has also been a rise in recent years in regards to the awareness among the population due to the interventions by the governments and NGOs.
Other factors such as the increasing age, changed lifestyle which is leading to issues like macular degeneration, cataract, diabetic retinopathy, and glaucoma are expected to propel the market as well. The major cause of the growth according to eye-related disorders is Macular degeneration, glaucoma, damage in the vision and aging are also affecting the growth of the fluorescein angiography market.
On the other hand, there has been a lack observed in the implementation of the stringent regulations by the governments and health insurance covers are hampering the fluorescein angiography market.
New product launches and acquisitions to flourish the market:
On January 2nd, 2019, Topcon Corporation received approval from the FDA and was called TRC-NW400 which made use of the AI system from a camera. This device was used for the diabetic retinopathy diagnosis.
On August 27th, 2019, Topcon introduced a new product named Maestro 2 Automated OCT or Fundus Camera.
Surge in usage in hospitals and ASCs applications:
Hospitals, academic research laboratories, Ambulatory Surgery Centers, and diagnostic centers are the major consumers of the fluorescein angiography market. Amongst them, Ambulatory surgery centers (ASCs) are the biggest end-users. The favorable reimbursement initiatives and policies by various insurance companies are helping the growth of the ASCs consumption.
Moreover, hospitals are also growing their demand due to the advances in the technologies.
Key benefits of the report:
- This study presents the analytical depiction of the global Fluorescein angiography industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Fluorescein angiography market share.
- The current market is quantitatively analyzed to highlight the global market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Fluorescein angiography market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Fluorescein angiography Market research report:
- What are the leading market players active in the Fluorescein angiography market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Fluorescein Angiography Market Report Highlights
Key Market Players
Heidelberg Engineering, Inc., Kowa Company Ltd, Topcon Medical Systems, Inc, Optomed Oy (Ltd)., Canon, Inc., XINDRAY MEDICAL INTERNATIONAL CO., LIMITED, Carl Zeiss, NIDEK Co., Ltd., , CenterVue SpA, Meditec, Inc